S-ClassAbout S-Class
C
CSTLAI Stock Diagnostic Report
Castle Biosciences surges 67% after InvestingPro Fair Value call
Castle Biosciences' stock price surged 67% due to the impact of InvestingPro's fair value assessment.
View Source Article ↗AI CATALYST SCORE85 / 100Score computed by Sentinel V12
REFERENCE PRICE$34.20000076293945Reference entry price at analysis time
01
MARKET SNAPSHOT
Key Indicators at a Glance
Major Support23.73
Near-Term Resistance34.70
02
FUNDAMENTALS
Financial & Fundamental Analysis
In response to InvestingPro's fair value assessment report, there has been a significant upward trend, indicating a phase where short-term market participants are entering the market.
03
TECHNICAL VIEW
Technical Position & Response Criteria
The current price is near the 20-day high resistance level ($34.70), so we need to monitor for a potential breakout and any short-term profit-taking sell orders.
Support23.73
Resistance34.70
04
CATALYST & STRATEGY
Catalyst Analysis & Forward Strategy
The InvestingPro Fair Value assessment for Castle Biosciences has acted as a catalyst, resulting in a 67% surge in its stock price.
05
PROOF OF WORK
Analysis Point vs. Subsequent Price Action
INITIAL · At Analysis (2026-08-23)
FINAL · Current/Verified
Renders the actual stored OHLC data directly in your browser.